HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.

AbstractBACKGROUND:
Liver fibrosis can progress to cirrhosis, hepatocellular carcinoma, or liver failure. Unfortunately, the antifibrotic agents are limited. Thrombin activates hepatic stellate cells (HSCs). Therefore, we investigated the effects of a direct thrombin inhibitor, dabigatran, on liver fibrosis.
METHODS:
Adult male Sprague-Dawley rats were injected intraperitoneally with thioacetamide (TAA, 200 mg/kg twice per week) for 8 or 12 weeks to induce liver fibrosis. The injured rats were assigned an oral gavage of dabigatran etexilate (30 mg/kg/day) or vehicle in the last 4 weeks of TAA administration. Rats receiving an injection of normal saline and subsequent oral gavage of dabigatran etexilate or vehicle served as controls.
RESULTS:
In the 8-week TAA-injured rats, dabigatran ameliorated fibrosis, fibrin deposition, and phosphorylated ERK1/2 in liver, without altering the transcript expression of thrombin receptor protease-activated receptor-1. In vitro, dabigatran inhibited thrombin-induced HSC activation. Furthermore, dabigatran reduced intrahepatic angiogenesis and portal hypertension in TAA-injured rats. Similarly, in the 12-week TAA-injured rats, a 4-week treatment with dabigatran reduced liver fibrosis and portal hypertension.
CONCLUSIONS:
By inhibiting thrombin action, dabigatran reduced liver fibrosis and intrahepatic angiogenesis. Dabigatran may be a promising therapeutic agent for treatment of liver fibrosis.
AuthorsKuei-Chuan Lee, Wei-Fan Hsu, Yun-Cheng Hsieh, Che-Chang Chan, Ying-Ying Yang, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 64 Issue 1 Pg. 102-112 (01 2019) ISSN: 1573-2568 [Electronic] United States
PMID30288660 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antithrombins
  • Thioacetamide
  • Fibrin
  • Collagen
  • Extracellular Signal-Regulated MAP Kinases
  • Dabigatran
Topics
  • Animals
  • Antithrombins (pharmacology)
  • Cell Line
  • Chemical and Drug Induced Liver Injury (etiology, metabolism, pathology, prevention & control)
  • Collagen (metabolism)
  • Cytoprotection
  • Dabigatran (pharmacology)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Fibrin (metabolism)
  • Hepatic Stellate Cells (drug effects, metabolism, pathology)
  • Hypertension, Portal (chemically induced, physiopathology, prevention & control)
  • Liver (drug effects, metabolism, pathology)
  • Liver Cirrhosis, Experimental (chemically induced, metabolism, pathology, prevention & control)
  • Male
  • Neovascularization, Pathologic
  • Phosphorylation
  • Portal Pressure (drug effects)
  • Rats, Sprague-Dawley
  • Thioacetamide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: